Charm Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Pancras Sq, London, Greater London, N1...Website
www.charmtx.comRevenue
$10.6 MillionIndustry
About Charm Therapeutics
Charm Therapeutics Org Chart
Is Charm Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Charm Therapeutics recently announced quarterly report
Charm Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Charm Therapeutics launches new products
Click to see if Charm Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Charm Therapeutics has new funding data
Check out if Charm Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Charm Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Charm Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Charm Therapeutics
Compare insights from companies similar to Charm Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Charm Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Charm Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Charm Therapeutics.
Charm Therapeutics financials insights
Gather financial insights about Charm Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$50M
Series B
$80M
Private Equity
$17.3M
Charm Therapeutics Tech Stack
A closer look at the technologies used by Charm Therapeutics
Most Recent Scoops
Charm Therapeutics News & Media
Charm offensive: Biotech startup raises $80m for leukemia drug - BioXconomy
London's Charm Therapeutics will use the capital to advance menin inhibitor cancer treatment.CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML
LONDON – 2 September 2025 -- CHARM Therapeutics (“CHARM”, “The Company”), announces closing of an oversubscribed Series B funding round, raising $80 million to advance its next generation menin inhibitor into clinical development. The financing was supported by a strong syndicate of both existing and new global investors, reflecting confidence in the Company's breakthrough approach to overcoming menin inhibitor resistance, a critical limitation for first-generation therapies.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Charm Therapeutics
CHARM Therapeutics is a biotechnology company pioneering the next generation of precision oncology treatments through its proprietary AI-driven drug discovery platform. CHARM's lead program is a next-generation menin inhibitor for the treatment of acute myeloid leukemia (AML).... Read More